welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
James Ford, MDDr. Ford is a medical oncologist and gen...
-
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal DiseaseThis study is being done to evaluate sin...
-
Dietary Calcium Supplementation for Preventing Colorectal Cancer and Adenomatous PolypsBACKGROUND : Several dietary factors hav...
-
Risk of Cancer and Secondary Proctectomy After Colectomy and Ileorectal Anastomosis in Familial Adenomatous Polyposi...PURPOSE : The aim of our retrospective s...
-
Appropriate Use of Endoscopy in the Diagnosis and Treatment of Gastrointestinal Diseases: Up-to-date Indications for...The field of endoscopy has revolutionize...
-
Desmoid Tumors: Clinical Features and Treatment Options for Advanced DiseaseDesmoid tumors describe a rare monoclona...
-
Ostomy: Diet and Nutrition GuideThis guide provides some basic informati...